Patents by Inventor David C. Duffy

David C. Duffy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11977087
    Abstract: Described are systems, devices, and methods which related to various aspects of assays for detecting and/or determining a measure of the concentration of analyte molecules or particles in a sample fluid. In some cases, the systems employ an assay consumable comprising a plurality of assay sites. The systems, devices, and/or methods, in some cases, are automated. In some cases, the systems, devices, and/or methods relate to inserting a plurality of beads into assay sites, sealing assay sites, imaging assay sites, or the like.
    Type: Grant
    Filed: August 6, 2021
    Date of Patent: May 7, 2024
    Assignee: Quanterix Corporation
    Inventors: David Fournier, Todd Campbell, Cheuk W. Kan, John Lawson, Andrew Rivnak, Michael Kagan, David C. Duffy
  • Publication number: 20230213510
    Abstract: Described herein are methods for improving the accuracy of capture object-based assays. In some embodiments, a measure of the number or a measure of the concentration of an analyte molecule or particle in a fluid sample is determined using the capture object-based assay.
    Type: Application
    Filed: December 8, 2022
    Publication date: July 6, 2023
    Applicant: Quanterix Corporation
    Inventors: David C. Duffy, David M. Rissin, Matthew Fishburn, Andrew Rivnak, Purvish Patel
  • Publication number: 20230109130
    Abstract: Methods and systems for capture object-based assays, including for determining a measure of the concentration of an analyte molecule or particle in a fluid sample, are described. The methods and systems may relate to high sensitivity detection of analytes, sometimes using assay conditions and sample handling that result in the capture and detection of a high percentage of the analyte molecules or particles in a fluid sample using relatively few capture objects. Apparatuses and methods for immobilizing capture objects with respect to assay sites, in some instances with unexpectedly high efficiencies are also described. Some such apparatuses involve the use of force fields and fluid meniscus forces, alone or in combination, to facilitate or improve capture object immobilization.
    Type: Application
    Filed: October 13, 2022
    Publication date: April 6, 2023
    Applicant: Quanterix Corporation
    Inventors: David C. Duffy, Nicholas Collier, Cheuk W. Kan, Carmen I. Tobos, David M. Rissin, Alexander D. Wiener, Ray Meyer, Christopher Warwick, Roger Millington, Danielle M. Svancara
  • Patent number: 11619631
    Abstract: The present invention relates to systems and methods for detecting analyte molecules or particles in a fluid sample and in some cases, determining a measure of the concentration of the molecules or particles in the fluid sample. Methods of the present invention may comprise immobilizing a plurality of analyte molecules or particles with respect to a plurality of capture objects. At least a portion of the plurality of capture objects may be spatially separated into a plurality of locations. A measure of the concentration of analyte molecules in a fluid sample may be determined, at least in part, on the number of reaction vessels comprising an analyte molecule immobilized with respect to a capture object. In some cases, the assay may additionally comprise steps including binding ligands, precursor labeling agents, and/or enzymatic components.
    Type: Grant
    Filed: April 11, 2019
    Date of Patent: April 4, 2023
    Assignee: Quanterix Corporation
    Inventors: David C. Duffy, David M. Rissin, David R. Walt, David Fournier, Cheuk Kan
  • Patent number: 11434264
    Abstract: Ultrasensitive and quantitative assays for detecting toxins of Clostridium difficile, which may involve digital ELISA, are provided. Also provided herein are differential detection assays that allow for distinguishing toxin B of highly virulent Clostridium difficile strains from toxin B of less virulent strains.
    Type: Grant
    Filed: February 12, 2016
    Date of Patent: September 6, 2022
    Assignees: Quanterix Corporation, Beth Israel Deaconess Medical Center, Inc.
    Inventors: Nira Pollock, Ciaran Kelly, David C. Duffy, Linan Song, Mingwei Zhao
  • Publication number: 20220205992
    Abstract: Described herein are materials and kits for associating species with a surface of an object. In some embodiments, the object comprises a plurality of capture objects (e.g., beads).
    Type: Application
    Filed: December 28, 2020
    Publication date: June 30, 2022
    Applicant: Quanterix Corporation
    Inventors: David M. Rissin, David C. Duffy
  • Publication number: 20220034917
    Abstract: Described are systems, devices, and methods which related to various aspects of assays for detecting and/or determining a measure of the concentration of analyte molecules or particles in a sample fluid. In some cases, the systems employ an assay consumable comprising a plurality of assay sites. The systems, devices, and/or methods, in some cases, are automated. In some cases, the systems, devices, and/or methods relate to inserting a plurality of beads into assay sites, sealing assay sites, imaging assay sites, or the like.
    Type: Application
    Filed: August 6, 2021
    Publication date: February 3, 2022
    Applicant: Quanterix Corporation
    Inventors: David Fournier, Todd Campbell, Cheuk W. Kan, John Lawson, Andrew Rivnak, Michael Kagan, David C. Duffy
  • Publication number: 20210311058
    Abstract: Described herein are systems and methods for extending the dynamic range of assay methods and systems used for determining the concentration of analyte molecules or particles in a fluid sample. In some embodiments, a method comprises spatially segregating a plurality of analyte molecules in a fluid sample into a plurality of locations. At least a portion of the locations may be addressed to determine the percentage of said locations containing at least one analyte molecule. Based at least in part on the percentage, a measure of the concentration of analyte molecules in the fluid sample may be determined using an analog, intensity-based detection/analysis method/system and/or a digital detection/analysis method/system. In some cases, the assay may comprise the use of a plurality of capture objects.
    Type: Application
    Filed: March 23, 2021
    Publication date: October 7, 2021
    Applicant: Quanterix Corporation
    Inventors: David M. Rissin, David Fournier, David C. Duffy
  • Patent number: 11112415
    Abstract: Described are systems, devices, and methods which related to various aspects of assays for detecting and/or determining a measure of the concentration of analyte molecules or particles in a sample fluid. In some cases, the systems employ an assay consumable comprising a plurality of assay sites. The systems, devices, and/or methods, in some cases, are automated. In some cases, the systems, devices, and/or methods relate to inserting a plurality of beads into assay sites, sealing assay sites, imaging assay sites, or the like.
    Type: Grant
    Filed: March 14, 2018
    Date of Patent: September 7, 2021
    Assignee: Quanterix Corporation
    Inventors: David Fournier, Todd Campbell, Cheuk Kan, John Lawson, Andrew Rivnak, Michael Kagan, David C. Duffy
  • Patent number: 10989713
    Abstract: Described herein are systems and methods for extending the dynamic range of assay methods and systems used for determining the concentration of analyte molecules or particles in a fluid sample. In some embodiments, a method comprises spatially segregating a plurality of analyte molecules in a fluid sample into a plurality of locations. At least a portion of the locations may be addressed to determine the percentage of said locations containing at least one analyte molecule. Based at least in part on the percentage, a measure of the concentration of analyte molecules in the fluid sample may be determined using an analog, intensity-based detection/analysis method/system and/or a digital detection/analysis method/system. In some cases, the assay may comprise the use of a plurality of capture objects.
    Type: Grant
    Filed: November 10, 2017
    Date of Patent: April 27, 2021
    Assignee: Quanterix Corporation
    Inventors: David M. Rissin, David Fournier, David C. Duffy
  • Publication number: 20200393457
    Abstract: The present invention relates to systems and methods for detecting analyte molecules or particles in a fluid sample and in some cases, determining a measure of the concentration of the molecules or particles in the fluid sample. Methods of the present invention may comprise immobilizing a plurality of analyte molecules or particles with respect to a plurality of capture objects. At least a portion of the plurality of capture objects may be spatially separated into a plurality of locations. A measure of the concentration of analyte molecules in a fluid sample may be determined, at least in part, on the number of reaction vessels comprising an analyte molecule immobilized with respect to a capture object. In some cases, the assay may additionally comprise steps including binding ligands, precursor labeling agents, and/or enzymatic components.
    Type: Application
    Filed: June 19, 2020
    Publication date: December 17, 2020
    Applicant: Quanterix Corporation
    Inventors: David C. Duffy, David M. Rissin, David R. Walt, David Fournier, Cheuk W. Kan
  • Publication number: 20200271643
    Abstract: Methods and systems for the detection of analyte molecules are generally described. In some embodiments, a method may comprise using a stabilizing agent prior to, during, and/or after one or more steps of a detection assay. The stabilizing agent may serve to maintain and/or increase the detectable signal indicative of the analyte during one or more assay steps and/or until the signal is measured. In such cases, the stabilizing agent may reduce and/or prevent one or more phenomena associated with signal decay, such as, e.g., dissociation between, aggregation of, and/or denaturation of analyte molecules and/or detection molecules. In some embodiments, the stabilizing agent can be used to improve the sensitivity of new and existing assays with little or no adverse effect on specificity. The methods and systems, described herein, may be used for a plethora of applications, including the detection or quantification of low levels of analyte molecules.
    Type: Application
    Filed: September 20, 2018
    Publication date: August 27, 2020
    Applicant: Quanterix Corporation
    Inventors: David Wilson, David M. Rissin, Lei Chang, Andrew Rivnak, David C. Duffy
  • Patent number: 10725032
    Abstract: The present invention relates to systems and methods for detecting analyte molecules or particles in a fluid sample and in some cases, determining a measure of the concentration of the molecules or particles in the fluid sample. Methods of the present invention may comprise immobilizing a plurality of analyte molecules or particles with respect to a plurality of capture objects. At least a portion of the plurality of capture objects may be spatially separated into a plurality of locations. A measure of the concentration of analyte molecules in a fluid sample may be determined, at least in part, on the number of reaction vessels comprising an analyte molecule immobilized with respect to a capture object. In some cases, the assay may additionally comprise steps including binding ligands, precursor labeling agents, and/or enzymatic components.
    Type: Grant
    Filed: April 14, 2017
    Date of Patent: July 28, 2020
    Assignee: Quanterix Corporation
    Inventors: David C. Duffy, David M. Rissin, David R. Walt, David Fournier, Cheuk Kan
  • Patent number: 10640814
    Abstract: Described herein are methods and systems for detecting DNA or RNA using single molecules array or other techniques. DNA or RNA from the sample may be fragmented and exposed to a first type of binding ligand and a second type of binding ligand that comprise nucleic acid sequences complimentary at least a portion of a sequence contained in the target DNA or RNA. At least a portion of the fragmented DNA or RNA associates with at least one of the first type of binding ligand and/or the second type of binding ligand, wherein the first type of binding ligand and second type of binding ligand comprises nucleic acid sequences complimentary to a different portions of a sequence contained in the DNA or RNA. A portion of the sample exposed to the binding ligands is analyzed to determine the number of fragmented DNA or RNA sequences.
    Type: Grant
    Filed: March 30, 2018
    Date of Patent: May 5, 2020
    Assignee: Quanterix Corporation
    Inventors: David C. Duffy, Linan Song, Dandan Shan, Mingwei Zhao
  • Publication number: 20200123592
    Abstract: Methods for detecting nucleic acids, particularly small nucleic acids such as microRNAs, involving the use of a peptide nucleic acid (PNA) probe that lacks a base and a labelled modified base corresponding to the omitted base in the PNA probe. A complex containing the target nucleic acid, the PNA probe, and the modified base can be determined using a single molecule array assay.
    Type: Application
    Filed: May 29, 2018
    Publication date: April 23, 2020
    Applicants: Quanterix Corporation, DestiNA Genomics Ltd.
    Inventors: Juan J. Díaz-Mochón, David C. Duffy, Salvatore Pernagallo, Hugh llyine, David M. Rissin, Barbara López-Longarela
  • Publication number: 20190302109
    Abstract: The present invention relates to systems and methods for detecting analyte molecules or particles in a fluid sample and in some cases, determining a measure of the concentration of the molecules or particles in the fluid sample. Methods of the present invention may comprise immobilizing a plurality of analyte molecules or particles with respect to a plurality of capture objects. At least a portion of the plurality of capture objects may be spatially separated into a plurality of locations. A measure of the concentration of analyte molecules in a fluid sample may be determined, at least in part, on the number of reaction vessels comprising an analyte molecule immobilized with respect to a capture object. In some cases, the assay may additionally comprise steps including binding ligands, precursor labeling agents, and/or enzymatic components.
    Type: Application
    Filed: April 11, 2019
    Publication date: October 3, 2019
    Applicant: Quanterix Corporation
    Inventors: David C. Duffy, David M. Rissin, David R. Walt, David Fournier, Cheuk Kan
  • Publication number: 20180363038
    Abstract: Described herein are methods and systems for detecting DNA or RNA using single molecules array or other techniques. DNA or RNA from the sample may be fragmented and exposed to a first type of binding ligand and a second type of binding ligand that comprise nucleic acid sequences complimentary at least a portion of a sequence contained in the target DNA or RNA. At least a portion of the fragmented DNA or RNA associates with at least one of the first type of binding ligand and/or the second type of binding ligand, wherein the first type of binding ligand and second type of binding ligand comprises nucleic acid sequences complimentary to a different portions of a sequence contained in the DNA or RNA. A portion of the sample exposed to the binding ligands is analyzed to determine the number of fragmented DNA or RNA sequences.
    Type: Application
    Filed: March 30, 2018
    Publication date: December 20, 2018
    Applicant: Quanterix Corporation
    Inventors: David C. Duffy, Linan Song, Dandan Shan, Mingwei Zhao
  • Publication number: 20180306830
    Abstract: Described are systems, devices, and methods which related to various aspects of assays for detecting and/or determining a measure of the concentration of analyte molecules or particles in a sample fluid. In some cases, the systems employ an assay consumable comprising a plurality of assay sites. The systems, devices, and/or methods, in some cases, are automated. In some cases, the systems, devices, and/or methods relate to inserting a plurality of beads into assay sites, sealing assay sites, imaging assay sites, or the like.
    Type: Application
    Filed: March 14, 2018
    Publication date: October 25, 2018
    Applicant: Quanterix Corporation
    Inventors: David Fournier, Todd Campbell, Cheuk Kan, John Lawson, Andrew Rivnak, Michael Kagan, David C. Duffy
  • Publication number: 20180224451
    Abstract: Described herein are systems and methods for extending the dynamic range of assay methods and systems used for determining the concentration of analyte molecules or particles in a fluid sample. In some embodiments, a method comprises spatially segregating a plurality of analyte molecules in a fluid sample into a plurality of locations. At least a portion of the locations may be addressed to determine the percentage of said locations containing at least one analyte molecule. Based at least in part on the percentage, a measure of the concentration of analyte molecules in the fluid sample may be determined using an analog, intensity-based detection/analysis method/system and/or a digital detection/analysis method/system. In some cases, the assay may comprise the use of a plurality of capture objects.
    Type: Application
    Filed: November 10, 2017
    Publication date: August 9, 2018
    Applicant: Quanterix Corporation
    Inventors: David M. Rissin, David Fournier, David C. Duffy
  • Patent number: 9952237
    Abstract: Described are systems, devices, and methods which related to various aspects of assays for detecting and/or determining a measure of the concentration of analyte molecules or particles in a sample fluid. In some cases, the systems employ an assay consumable comprising a plurality of assay sites. The systems, devices, and/or methods, in some cases, are automated. In some cases, the systems, devices, and/or methods relate to inserting a plurality of beads into assay sites, sealing assay sites, imaging assay sites, or the like.
    Type: Grant
    Filed: February 25, 2011
    Date of Patent: April 24, 2018
    Assignee: Quanterix Corporation
    Inventors: David Fournier, Todd Campbell, Cheuk Kan, John Lawson, Andrew Rivnak, Michael Kagan, David C. Duffy